Exercise Programs in Women With PCOS
Starting soon · Not applicable
Conditions studied: Polycystic Ovarian Syndrome (PCOS)
In brief
This study aims to investigate the effectiveness of a digital rehabilitation-supported combined exercise program in women with Polycystic Ovary Syndrome (PCOS). Participants aged 18-40 years will be randomly assigned to one of three groups: a digital rehabilitation group, a face-to-face exercise group, and a physical activity counseling group. The intervention will last 8 weeks, with exercise performed three times per week. Outcomes will include DNA methylation, hormonal and metabolic parameters, anthropometric measurements, body composition, muscle strength, basal metabolic rate, physical activity level, quality of life, menstrual cycle regularity, exercise adherence and satisfaction.
Key facts
- Study ID
- NCT07509762
- Run by
- Biruni University
- People needed
- 33
- Starts
- 2026-09-01
- Expected to finish
- 2027-03-25
- Last updated by the study team
- 2026-06-17
Who can join
Age: 18 and older, up to 40. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Women aged 18-40 years diagnosed with PCOS according to the Rotterdam criteria (Rotterdam, 2003) and by a specialist physician.
- The presence of at least two of the following three criteria will be considered sufficient for a diagnosis of PCOS according to the Rotterdam criteria: (i) history of irregular menstruation with oligo/anovulation, (ii) clinical and/or biochemical signs of hyperandrogenism, (iii) detection of polycystic ovary images on ultrasonography.
- Having sufficient technological skills to participate in the treatment online (ability to use video conferencing applications)
- Voluntary participation in the study
You may not qualify if…
- Pregnant and breastfeeding women
- Individuals with acute infections
- Uncontrolled arrhythmia, hypertension, diabetes, and unstable angina pectoris
- Impaired cooperation, orthopedic and neurological problems that may hinder assessment and program participation
- Individuals with a history of lower extremity injury or surgery in the last six months
- Individuals with class III obesity according to WHO classification (BMI > 40 kg/m2) (WHO, 2000)
- Individuals receiving medical treatment for weight loss (liraglutide, semaglutide, orlistat, bupropion/naltrexone, thizzpatide) or participating in a structured diet program during the study period
- Individuals actively participating in another exercise program
- Individuals taking antihypertensive, insulin-sensitizing, or hormonal contraceptive drugs in the last 3 months
Where it is running
- Biruni University — Istanbul, Turkey (Türkiye)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.